Breast Mesh Used in Two-staged Breast Reconstruction
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Study ID
- NCT04967976
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Reconstruction
- Radiation
- Synthetic Mesh
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- TiLoop Bra mesh in expander-implant breast reconstrution — PROCEDUREThe tissue expander is inserted with TiLoop Bra mesh in the first stage of reconstruction immediately after nipple/skin-sparing mastectomy. The tissue expander is placed sub-pectoral.
- sub-pectoral expander-implant breast reconstruction — PROCEDUREThe tissue expander is inserted without TiLoop Bra mesh in the first stage of reconstruction immediately after nipple/skin-sparing mastectomy. The tissue expander is placed sub-pectoral and covered by muscle/fascia.
Study Details
This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
Key Dates
- Start date
- Aug 1, 2021
- Status verified
- Apr 2021
- Primary completion
- Aug 1, 2023
- Completion
- Aug 1, 2026
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Breast Reconstruction with breast meshThe tissue expander-implant reconstruction with TiLoop Bra mesh.
- Active Comparator: Breast Reconstruction without breast meshThe tissue expander-implant reconstruction without TiLoop Bra mesh. The tissue expander is placed sub-pectoral and covered by muscle/fascia.
Primary Outcome Measure
Complication Rates [ Time Frame: up to 24 months after surgery ]
Central Contacts
- Jian Yin+86-22-23340123
- Bowen Ding+86-22-23340123
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Edward Chang |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska